HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Birgit Bremer Selected Research

Hepatitis D

1/2022HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta.
1/2021Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study.
1/2021A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction.
1/2017Antiviral treatment and liver-related complications in hepatitis delta.
7/2014Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta.
1/2014Anti-HDV IgM as a marker of disease activity in hepatitis delta.
10/2012HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.
1/2012Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment.
6/2010Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Birgit Bremer Research Topics

Disease

17Infections
11/2022 - 01/2010
9Hepatitis D
01/2022 - 06/2010
6Hepatitis B
11/2022 - 10/2012
4Hepatocellular Carcinoma (Hepatoma)
01/2018 - 10/2012
4Chronic Hepatitis (Chronic Active Hepatitis)
10/2016 - 01/2010
4Liver Diseases (Liver Disease)
05/2014 - 01/2010
3Chronic Hepatitis B
11/2022 - 01/2020
3Hepatitis
01/2021 - 01/2010
3Fibrosis (Cirrhosis)
01/2017 - 01/2014
3Viremia
01/2014 - 01/2010
2Hepatitis C
01/2021 - 01/2014
2Hepatitis E
01/2020 - 01/2014
2Disease Progression
01/2017 - 01/2014
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2014 - 01/2010
1Communicable Diseases (Infectious Diseases)
01/2021
1Hemorrhage
01/2017
1Ascites
01/2017
1Brain Diseases (Brain Disorder)
01/2017
1Chronic Pancreatitis
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2016
1Autoimmune Diseases (Autoimmune Disease)
01/2014
1Rheumatoid Arthritis
01/2014
1Chronic Hepatitis C
01/2014
1Inflammation (Inflammations)
01/2010

Drug/Important Bio-Agent (IBA)

13RNA (Ribonucleic Acid)IBA
01/2021 - 01/2010
6InterferonsIBA
01/2022 - 06/2010
6Antiviral Agents (Antivirals)IBA
01/2021 - 01/2012
4Biomarkers (Surrogate Marker)IBA
11/2022 - 01/2014
3AntigensIBA
11/2022 - 08/2016
3Hepatitis B e AntigensIBA
11/2022 - 10/2012
3Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2022 - 01/2021
3Interferon-alpha (Interferon Alfa)IBA
01/2022 - 01/2014
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 10/2012
3Ribavirin (Virazole)FDA LinkGeneric
01/2018 - 01/2014
3AntibodiesIBA
10/2014 - 01/2010
2Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2014
2Immunoglobulin M (IgM)IBA
01/2014 - 01/2012
1Circular DNAIBA
01/2022
1SuspensionsIBA
01/2022
1B7-H1 AntigenIBA
01/2021
1InterleukinsIBA
01/2021
1LigandsIBA
01/2021
1Lymphotoxin-alpha (Lymphotoxin)IBA
01/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2021
1ChemokinesIBA
01/2021
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1Caspase 8 (Caspase-8)IBA
01/2021
1OsteoprotegerinIBA
01/2021
1peginterferon alfa-2a (Pegasys)FDA Link
01/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2020
14-(1'-heptylnonyl)benzenesulfonateIBA
01/2020
1Viral RNAIBA
01/2018
1Capsid Proteins (Capsid Protein)IBA
01/2018
1Cholinesterases (Cholinesterase)IBA
01/2017
1TransferasesIBA
01/2017
1AlbuminsIBA
01/2017
1Peptides (Polypeptides)IBA
01/2016
1SofosbuvirIBA
01/2016
1Surface Antigens (Surface Antigen)IBA
10/2014
1Hepatitis B AntibodiesIBA
10/2014
1Hepatitis C AntibodiesIBA
10/2014
1Pharmaceutical PreparationsIBA
07/2014
1adefovirIBA
07/2014
1CytokinesIBA
05/2014
1telaprevirIBA
01/2014
1Prednisolone (Predate)FDA LinkGeneric
01/2014
1Protease Inhibitors (Protease Inhibitor)IBA
01/2014
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2014
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2014
1Interferon Type IIBA
01/2012
1Immunoglobulin G (IgG)IBA
01/2010

Therapy/Procedure

12Therapeutics
11/2022 - 01/2012
6Liver Transplantation
01/2021 - 01/2010
2Transplantation
03/2012 - 01/2010